nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CHRM3—GPCR ligand binding—P2RY11—narcolepsy	0.00293	0.00293	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00293	0.00293	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00292	0.00292	CbGpPWpGaD
Tolterodine—CHRM3—GPCRs, Other—HTR2A—narcolepsy	0.00292	0.00292	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00291	0.00291	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00289	0.00289	CbGpPWpGaD
Tolterodine—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00289	0.00289	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—TRH—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Tolterodine—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.00273	0.00273	CbGpPWpGaD
Tolterodine—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.00273	0.00273	CbGpPWpGaD
Tolterodine—CHRM3—G alpha (q) signalling events—TAC1—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Tolterodine—CHRM3—G alpha (q) signalling events—NPS—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Tolterodine—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.00271	0.00271	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—TRH—narcolepsy	0.00269	0.00269	CbGpPWpGaD
Tolterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00268	0.00268	CbGpPWpGaD
Tolterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00268	0.00268	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.00258	0.00258	CbGpPWpGaD
Tolterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Tolterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—HCRTR2—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—HCRTR1—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Tolterodine—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Tolterodine—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Tolterodine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.0025	0.0025	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—HCRT—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00247	0.00247	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—P2RY11—narcolepsy	0.00247	0.00247	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—HRH3—narcolepsy	0.00247	0.00247	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00246	0.00246	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—HCRTR1—narcolepsy	0.00245	0.00245	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—HCRTR2—narcolepsy	0.00245	0.00245	CbGpPWpGaD
Tolterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00244	0.00244	CbGpPWpGaD
Tolterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00244	0.00244	CbGpPWpGaD
Tolterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00244	0.00244	CbGpPWpGaD
Tolterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00244	0.00244	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—P2RY11—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—HRH3—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Tolterodine—CHRM5—G alpha (q) signalling events—HTR2A—narcolepsy	0.00233	0.00233	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—HCRTR2—narcolepsy	0.00232	0.00232	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—HCRTR1—narcolepsy	0.00232	0.00232	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—P2RY11—narcolepsy	0.00224	0.00224	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.00223	0.00223	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—PENK—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—HCRTR1—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—HCRTR2—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.0022	0.0022	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00218	0.00218	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00218	0.00218	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00216	0.00216	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—P2RY11—narcolepsy	0.00215	0.00215	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—HCRT—narcolepsy	0.0021	0.0021	CbGpPWpGaD
Tolterodine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—TAC1—narcolepsy	0.00204	0.00204	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—NPS—narcolepsy	0.00204	0.00204	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—HCRT—narcolepsy	0.00201	0.00201	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—TAC1—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—NPS—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—HCRT—narcolepsy	0.0019	0.0019	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.0019	0.0019	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.00189	0.00189	CbGpPWpGaD
Tolterodine—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00188	0.00188	CbGpPWpGaD
Tolterodine—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00188	0.00188	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00187	0.00187	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—PENK—narcolepsy	0.00187	0.00187	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—HCRT—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00181	0.00181	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00181	0.00181	CbGpPWpGaD
Tolterodine—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0018	0.0018	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0018	0.0018	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0018	0.0018	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—PENK—narcolepsy	0.00179	0.00179	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00179	0.00179	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00179	0.00179	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00172	0.00172	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00172	0.00172	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00172	0.00172	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00172	0.00172	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—PENK—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Tolterodine—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00164	0.00164	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00164	0.00164	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00164	0.00164	CbGpPWpGaD
Tolterodine—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.00164	0.00164	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—PENK—narcolepsy	0.00163	0.00163	CbGpPWpGaD
Tolterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—TRH—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Tolterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—TRH—narcolepsy	0.00152	0.00152	CbGpPWpGaD
Tolterodine—KCNH2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00152	0.00152	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00149	0.00149	CbGpPWpGaD
Tolterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Tolterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—TRH—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—HRH3—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—TRH—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HCRTR1—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HCRTR2—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—HRH3—narcolepsy	0.00133	0.00133	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—P2RY11—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HCRTR2—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HCRTR1—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Tolterodine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—P2RY11—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Tolterodine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—HRH3—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Tolterodine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00125	0.00125	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CHKB—narcolepsy	0.00125	0.00125	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—HTR2A—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—HRH3—narcolepsy	0.00121	0.00121	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—HTR2A—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—TAC1—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—NPS—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.00114	0.00114	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.00114	0.00114	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00113	0.00113	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00113	0.00113	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HCRT—narcolepsy	0.00113	0.00113	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—NPS—narcolepsy	0.00111	0.00111	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—TAC1—narcolepsy	0.00111	0.00111	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HCRT—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00106	0.00106	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—TAC1—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—NPS—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—NPS—narcolepsy	0.001	0.001	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—TAC1—narcolepsy	0.001	0.001	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PENK—narcolepsy	0.001	0.001	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.000973	0.000973	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.00097	0.00097	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.000961	0.000961	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PENK—narcolepsy	0.00096	0.00096	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.00094	0.00094	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.000937	0.000937	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.000928	0.000928	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000924	0.000924	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000924	0.000924	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.000921	0.000921	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.000921	0.000921	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.000912	0.000912	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.000912	0.000912	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.000892	0.000892	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.00089	0.00089	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.000881	0.000881	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.000854	0.000854	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TRH—narcolepsy	0.000853	0.000853	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.000851	0.000851	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CPT1B—narcolepsy	0.00085	0.00085	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.000843	0.000843	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.000829	0.000829	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.000826	0.000826	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.000818	0.000818	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TRH—narcolepsy	0.000817	0.000817	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CHKB—narcolepsy	0.000813	0.000813	CbGpPWpGaD
Tolterodine—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000807	0.000807	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.000779	0.000779	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.000779	0.000779	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.000776	0.000776	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.000776	0.000776	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.000769	0.000769	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.000769	0.000769	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.000759	0.000759	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.000756	0.000756	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.000749	0.000749	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CHKB—narcolepsy	0.000748	0.000748	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HRH3—narcolepsy	0.000748	0.000748	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CHKB—narcolepsy	0.000742	0.000742	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HRH3—narcolepsy	0.000716	0.000716	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.000707	0.000707	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.000707	0.000707	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.000705	0.000705	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.000705	0.000705	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.000698	0.000698	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.000698	0.000698	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—HTR2A—narcolepsy	0.000695	0.000695	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PENK—narcolepsy	0.000676	0.000676	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PENK—narcolepsy	0.000674	0.000674	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PENK—narcolepsy	0.000668	0.000668	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—HTR2A—narcolepsy	0.000665	0.000665	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—HTR2A—narcolepsy	0.000631	0.000631	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NPS—narcolepsy	0.00062	0.00062	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TAC1—narcolepsy	0.00062	0.00062	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—HTR2A—narcolepsy	0.000604	0.000604	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TAC1—narcolepsy	0.000593	0.000593	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NPS—narcolepsy	0.000593	0.000593	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TRH—narcolepsy	0.000575	0.000575	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TRH—narcolepsy	0.000573	0.000573	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TRH—narcolepsy	0.000568	0.000568	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CPT1B—narcolepsy	0.000553	0.000553	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000508	0.000508	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.000504	0.000504	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CPT1B—narcolepsy	0.000504	0.000504	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.000503	0.000503	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.000498	0.000498	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CHKB—narcolepsy	0.000489	0.000489	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000469	0.000469	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.000467	0.000467	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.000463	0.000463	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000425	0.000425	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.000424	0.000424	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.00042	0.00042	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.000418	0.000418	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NPS—narcolepsy	0.000418	0.000418	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NPS—narcolepsy	0.000416	0.000416	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.000416	0.000416	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.000412	0.000412	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NPS—narcolepsy	0.000412	0.000412	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HTR2A—narcolepsy	0.000373	0.000373	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HTR2A—narcolepsy	0.000357	0.000357	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000332	0.000332	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000251	0.000251	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.000251	0.000251	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000248	0.000248	CbGpPWpGaD
